WHO declares Dolutegravir safe for all populations HEALTH | JULIAN SABIITI | Pregnant women and those of childbearing potential can now use the HIV drug Dolutegravir (DTG). The World Health Organisation (WHO) made the recommendation in a statement released on July 22. The WHO statement was a reversal of a …
Read More »Dolutegravir recommended as preferred HIV treatment option
WHO recommends dolutegravir as preferred HIV treatment option in all populations Mexico City, Mexico | THE INDEPENDENT | Based on new evidence assessing benefits and risks, the World Health Organisation (WHO) has recommended the use of the HIV drug dolutegravir (DTG) as the preferred first-line and second-line treatment for all …
Read More »